Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 439 of 6351
-
Could a simple supplement boost IVF success?
Disease control Recruiting nowThe goal of this clinical trial is to learn whether supplementation with L-carnitine improves outcomes in women undergoing in vitro fertilization (IVF). It will also evaluate the effect of supplementation on oocyte quality, embryo quality, and pregnancy rates. The main questions …
Sponsor: The Obstetrics and Gynaecology Clinic Narodni Front • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New hope for kids with tough brain cancers: experimental drug trial launches
Disease control Not yet recruitingIn this study, we want to find out more about the side effects of an investigational drug for relapsed or refractory atypical teratoid rhabdoid tumor and high-grade glioma, Gallium Maltolate (GaM) and what doses of GaM are safe for people to take. Everyone in this study will rece…
Phase 1 • Sponsor: Sarah Rumler • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Engineered immune cells take on Hard-to-Treat myeloma
Disease control Recruiting nowThis is a phase I, interventional, single-arm, open-label, dose-finding treatment study designed to evaluate the safety and efficacy of interleukin-7(IL-7) / interleukin-15 (IL-15) manufactured CAR T cells in adult patients with relapsed and/or refractory myeloma that have failed…
Phase 1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Precision radiation and immunotherapy join forces against inoperable stomach cancer
Disease control Recruiting nowThe purpose of this prospective, single-center, phase II study is to evaluate the clinical efficacy and safety of combining first-line systemic therapy plus immunotherapy with personalized ultrafractionated stereotactic adaptive radiation therapy (PULSAR) in patients with unresec…
Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New blood test could spot cervical cancer early in High-Risk women
Diagnosis Not yet recruitingThis prospective, multicenter cohort study will recruit eligible HPV16/18-positive women from three tertiary hospitals in China. Peripheral blood samples and clinical data (cytology, HPV genotyping, colposcopy-directed biopsy) will be collected, followed by standardized mass cyto…
Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
AI socrates for med students: a smarter way to learn?
Knowledge-focused Recruiting nowPrior to the quasi-experiment, this study performed semi-structured interviews among Bachelor of Medicine and Bachelor of Surgery(MBBS) undergraduate students from the Belt and Road International Medical College, Zhejiang University. Based on learning science, cognitive load theo…
Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Could play be a lifeline for children of war? a major study investigates
Knowledge-focused OngoingThe iRRRd study is an ongoing prospective longitudinal prenatal birth cohort study based in Cox's Bazar, Bangladesh. Between February 2023 and March 2024, 2,888 pregnant women were enrolled (approximately 80% Rohingya refugees living in camps, 20% Bangladeshi host community). The…
Sponsor: New York University • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
New pill could help vapers kick the habit for good
Disease control Not yet recruitingThis will be a multi-center, double-blind, randomized, placebo-controlled, Phase 3 study conducted in male or female adults who are daily nicotine e-cigarette users only. A total of approximately 800 subjects will be randomly assigned (1:1) to one of two Arms: * Arm B, 12 weeks…
Phase 3 • Sponsor: Achieve Life Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New combo therapy aims to boost rectal cancer survival
Disease control Recruiting nowThis study is a national multicenter, prospective randomized, placebo- controlled Phase III clinical trial designed to investigate the potential therapeutic benefit of immunotherapy combined with total neoadjuvant therapy (TNT) and to compare the efficacy of different radiotherap…
Phase 3 • Sponsor: Tao Zhang • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New combo therapy aims to outsmart drug-resistant lung cancer
Disease control Not yet recruitingThe goal of this clinical trial is to learn if Osimertinib plus Capivasertib works to treat EGFRm advanced non-small cell lung cancer (NSCLC) in participants with PIK3CA/AKT1/PTEN alterations after progression on first-line Osimertinib (monotherapy or plus chemotherapy). The mai…
Phase 1/2 • Sponsor: Shanxi Province Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could one stem cell infusion slow Alzheimer's decline?
Disease control Recruiting nowThe purpose of this study is to test if adding one infusion of (Human Mesenchymal Stem Cells) hMSCs to the treatment with standard of care (SOC) monoclonal antibodies (mAb) will stabilize the rate of cognitive and functional decline associated with mild Alzheimer's Disease.
Phase 2 • Sponsor: Bernard (Barry) Baumel • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New antibody drug aims to block Brain-Attacking autoantibodies
Disease control Recruiting nowThis study will evaluate the safety, tolerability, preliminary efficacy and pharmacokinetics (PK) of ART5803 in adult participants with a confirmed diagnosis of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis (ANRE) or anti-NMDAR autoantibody-associated psychiatric diseas…
Phase 2 • Sponsor: Arialys Australia Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Promising combo may slash radiation harm in rare lymphoma
Disease control Not yet recruitingExtranodal NK/T-cell lymphoma (ENKTCL) is an Epstein-Barr virus-associated non-Hodgkin lymphoma with high incidence in Asia and Latin America. Approximately 70% of patients present with early-stage (I-II) disease confined to the upper aerodigestive tract. Radiotherapy at 50-56 Gy…
Phase 2 • Sponsor: Beijing Tongren Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Sound waves may shield heart attack survivors from deadly rhythm problems
Disease control Recruiting nowThe goal of this multicenter, double-blind, randomized controlled trial is to evaluate the efficacy and safety of low-intensity focused ultrasound (LIFU) stellate ganglion modulation for preventing ventricular arrhythmias after ST-segment elevation myocardial infarction (STEMI) i…
Sponsor: Renmin Hospital of Wuhan University • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New combo therapy aims to outperform standard care for advanced liver cancer
Disease control Recruiting nowThe purpose of this prospective, randomized, multicenter, controlled clinical study is to evaluate the efficacy and safety of hepatic arterial infusion chemotherapy (HAIC) compared to transarterial chemoembolization (TACE) when both are combined with sintilimab and bevacizumab fo…
Phase 3 • Sponsor: Binkui Li • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug trial aims to slow liver disease in rare bile duct condition
Disease control Recruiting nowThe purpose of this study is to find out how well and safely elafibranor works compared to placebo in adult participants with Primary sclerosing cholangitis (PSC). PSC is a rare disease that causes inflammation and scarring of the bile ducts in the liver. Over time, this can lead…
Phase 3 • Sponsor: Ipsen • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Video games as therapy? a trial tests Movement-Based play for autism motor skills
Symptom relief CompletedThe goal of this study is to learn if movement-based digital games can help improve motor skills in children aged 6-10 years with Autism Spectrum Disorder (ASD). The main question this study aims to answer is: \* Do children who take part in movement-based digital games show gr…
Sponsor: Burdur Mehmet Akif Ersoy University • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Could a natural brain booster help stroke survivors walk again?
Disease control Recruiting nowStroke is a leading cause of global mortality and morbidity, with acute ischemic stroke (AIS) accounting for approximately 65.3% of cases and resulting in roughly 3.4 million new cases annually in China. While endovascular thrombectomy (EVT) is the recommended first-line therapy …
Phase 4 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could a new injection help people with New-Onset type 1 diabetes keep making insulin?
Disease control Recruiting nowThis Phase 2 study is a 2-arm, multi-center, double-masked (masking of the participant, care provider and investigator), placebo-controlled, 2:1 randomized trial design in new onset T1D participants (within 100 days of diagnosis). Participants will be administered rezpegaldesleuk…
Phase 2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New hope for liver cancer patients: drug combo trial launches
Disease control Recruiting nowThis is a Phase 2, multicenter, randomized, open-label study designed to evaluate the efficacy and safety of fostrox in combination with lenvatinib compared with lenvatinib alone in patients with locally advanced or unresectable advanced hepatocellular carcinoma (HCC) who have ex…
Phase 2 • Sponsor: CHA University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC